ArticleLaboratory investigation; a journal of technical methods and pathology2018

Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma.

Weijian Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.